Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oxidative phosphorylation disease diagnosis.

J M Shoffner1

  • 1Molecular Medicine Laboratory, Children's Healthcare of Atlanta, Georgia 30342, USA.

Annals of the New York Academy of Sciences
|February 15, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular analysis of oxidative phosphorylation diseases for detection of mitochondrial DNA mutations.

Current protocols in human genetics·2008
Same author

An introduction: oxidative phosphorylation diseases.

Seminars in neurology·2001
Same author

Oxidative phosphorylation disease diagnosis.

Seminars in neurology·2000
Same author

Mitochondrial myopathy diagnosis.

Neurologic clinics·2000
Same author

Tau pathology in a family with dementia and a P301L mutation in tau.

Journal of neuropathology and experimental neurology·1999
Same author

Oxidative phosphorylation defects and Alzheimer's disease.

Neurogenetics·1997

Mitochondrial DNA (mtDNA) and nuclear DNA mutations cause oxidative phosphorylation (OXPHOS) diseases. Recent discoveries improve diagnosis, management, and genetic counseling for these complex conditions.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • Oxidative phosphorylation (OXPHOS) requires approximately 1,000 proteins, yet only 13 are encoded by mitochondrial DNA (mtDNA).
  • Over the last decade, numerous adult and pediatric OXPHOS diseases have been linked to mutations in both mtDNA and nuclear DNA (nDNA).

Purpose of the Study:

  • To review recent advances in understanding OXPHOS diseases.
  • To discuss the impact of newly identified nDNA and mtDNA mutations on disease pathogenesis.
  • To highlight improvements in diagnosing and managing OXPHOS disorders.

Main Methods:

  • Review of recent scientific literature on OXPHOS diseases.
  • Analysis of newly identified mtDNA and nDNA mutations.
  • Discussion of diagnostic and genetic counseling advancements.

Related Experiment Videos

Main Results:

  • Identification of a wide spectrum of OXPHOS diseases associated with mtDNA and nDNA mutations.
  • Enhanced diagnostic capabilities for patients with OXPHOS disorders.
  • Improved understanding of the genetic basis and pathogenesis of OXPHOS diseases.

Conclusions:

  • Advances in identifying mtDNA and nDNA mutations have significantly improved the diagnosis and management of OXPHOS diseases.
  • Continued research into these mutations is crucial for further understanding disease mechanisms.
  • Genetic counseling for families affected by OXPHOS disorders has been enhanced by these discoveries.